DIN 02430932 — TRIUMEQ 50 MG; 600 MG; 300 MG
TRIUMEQ is a tablet of Abacavir / Dolutegravir / Lamivudine marketed by VIIV HEALTHCARE ULC. The full Abacavir / Dolutegravir / Lamivudine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02430932
- Brand name
- TRIUMEQ
- Active ingredient
- Abacavir / Dolutegravir / Lamivudine
- Strength
- 50 MG; 600 MG; 300 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- VIIV HEALTHCARE ULC
- Health Canada status
- MARKETED
- Drug class
- Antiretroviral agent - fixed-dose combination integrase inhibitor with two nucleoside reverse transcriptase inhibitors
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.